| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Epidemiology and Prevention |
-Glutamyl-Se- methylselenocysteine
Department of Experimental Pathology, Roswell Park Cancer Institute, Buffalo, New York 14263 [Y. D., C. I.]; Department of Fruit and Vegetable Science, Cornell University, Ithaca, New York 14853 [D. L.]; and Department of Chemistry, State University of New York at Albany, Albany, New York 12222 [E. B.]
-Glutamyl-Se-methylselenocysteine (GGMSC) has recently been identified as the major Se compound in natural garlic and selenized garlic. Our working hypothesis is that GGMSC serves primarily as a carrier of Se-methylselenocysteine (MSC), which has been demonstrated in past research to be a potent cancer chemopreventive agent in animal carcinogenesis bioassays. The present study was designed to examine the in vivo responses to GGMSC or MSC using a variety of biochemical and biological end points, including (a) urinary Se excretion as a function of bolus dose; (b) tissue Se accumulation profile; (c) anticancer efficacy; and (d) gene expression changes as determined by cDNA array analysis. Our results showed that like MSC, GGMSC was well absorbed p.o., with urinary excretion as the major route for eliminating excess Se. When fed chronically, the profile of Se accumulation in various tissues was very comparable after treatment with either GGMSC or MSC. In rats that had been challenged with a carcinogen, supplementation with either GGMSC or MSC resulted in a lower prevalence of premalignant lesions in the mammary gland, and fewer mammary carcinomas when these early lesions were allowed to progress. More importantly, we found that a short term GGMSC/MSC treatment schedule of 4 weeks immediately after carcinogen dosing was sufficient to provide significant cancer protection, even in the absence of a sustained exposure past the initial 4-week period. With the use of the Clontech Atlas Rat cDNA Array, we further discovered that the gene expression changes induced in mammary epithelial cells of rats that were given either GGMSC or MSC showed a high degree of concordance. On the basis of the collective biology, biochemistry, and molecular biology data, we conclude that GGMSC is an effective anticancer agent with a mechanism of action very similar to that of MSC.
This article has been cited by other articles:
![]() |
J.-I. Lee, H. Nian, A. J.L. Cooper, R. Sinha, J. Dai, W. H. Bisson, R. H. Dashwood, and J. T. Pinto {alpha}-Keto Acid Metabolites of Naturally Occurring Organoselenium Compounds as Inhibitors of Histone Deacetylase in Human Prostate Cancer Cells Cancer Prevention Research, July 1, 2009; 2(7): 683 - 693. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Zhang and H. Zarbl Chemopreventive Doses of Methylselenocysteine Alter Circadian Rhythm in Rat Mammary Tissue Cancer Prevention Research, July 1, 2008; 1(2): 119 - 127. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Milner Preclinical Perspectives on Garlic and Cancer J. Nutr., March 1, 2006; 136(3): 827S - 831S. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Tsuneyoshi, J. Yoshida, and T. Sasaoka Hydroponic Cultivation Offers A Practical Means of Producing Selenium-Enriched Garlic J. Nutr., March 1, 2006; 136(3): 870S - 872S. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W. FINLEY Proposed Criteria for Assessing the Efficacy of Cancer Reduction by Plant Foods Enriched in Carotenoids, Glucosinolates, Polyphenols and Selenocompounds Ann. Bot., June 1, 2005; 95(7): 1075 - 1096. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Filomeni, K. Aquilano, G. Rotilio, and M. R. Ciriolo Reactive Oxygen Species-dependent c-Jun NH2-terminal Kinase/c-Jun Signaling Cascade Mediates Neuroblastoma Cell Death Induced by Diallyl Disulfide Cancer Res., September 15, 2003; 63(18): 5940 - 5949. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. D. Whanger Selenocompounds in Plants and Animals and their Biological Significance J. Am. Coll. Nutr., June 1, 2002; 21(3): 223 - 232. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Dong, H. E. Ganther, C. Stewart, and C. Ip Identification of Molecular Targets Associated with Selenium-induced Growth Inhibition in Human Breast Cells Using cDNA Microarrays Cancer Res., February 1, 2002; 62(3): 708 - 714. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Zhu, W. Jiang, H. E. Ganther, and H. J. Thompson Mechanisms of Cell Cycle Arrest by Methylseleninic Acid Cancer Res., January 1, 2002; 62(1): 156 - 164. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |